Future Market Insights
The use of genetically engineered mice in experimental medical research have led to significant advances to understand the disease and human health. The development of gene targeting and transgenic methods and recent innovations in gene-editing technologies, the manipulation of the mouse genome have become more refined. There is an extensive genetic similarity between humans and mice; it is also recognized that even very subtle sequence differences between the two species can have important functional consequences for the respective individual gene functions. Also, some genes have been identified in humans that do not have orthologous mouse counterparts. This divergence limits the utility of mouse models in predicting gene function as a reliable tool for preclinical research. These genetically “humanized” mice have the potential to provide more reliable in vivo data concerning human gene function in normal physiology and disease. As a result, there is growing interest in the generation of genetically engineered mice that express an orthologous human gene.
Humanized Mouse Model Market: Drivers and Restraints
Continuous support for research activities in the form of grants and investments, increased R&D activities by biotechnology and pharmaceutical companies, the surge in the number of research activities involving humanized mouse models, and growing consumption of personalized medicines have attributed to the growth of overall humanized mouse model market. The CD34 cell based humanized mouse model segment is expected to have a larger share in the cell-based humanized mouse model market. These model are used for long-term studies in the fields of immuno-oncology, host disease, and infectious disease. Thus, the growing application areas of CD34 models are expected to trigger the demand for these models.
Humanized Mouse Model Market: Segmentation
By model type, the humanized mouse model market can be segmented into,
Genetic Humanized Mouse Model
Cell-based Humanized Mouse Model
By application, the humanized mouse model market can be segmented into,
Immunology and Infectious Diseases
By end user, the humanized mouse model market can be segmented into,
Pharmaceutical & Biotechnology Companies
Contract Research Organizations
Academic & Research Institutions
The growth of these segments is attributed due to growing funds from various governments to carry out increasing research activities and research studies in cancer.
Humanized Mouse Model Market: Overview
This technology can be used to produce animal models with the more humanized pathological condition, including genetic disorder. This model can also be used to determine drug effectiveness and metabolism that have normal physiological environments such as human organ function and microbial flora. Since disease models reflecting human physiology faithfully can be produced and used for more accurate non-clinical study and drug discovery, high demand from researchers is expected. Also, accelerated growth of Transgenic Group is anticipated by generating synergy effect between genomics business division manufacturing humanized mouse products and CRO business division that conduct non-clinical study using humanized mouse models.
Humanized Mouse Model Market: Region-wise Outlook
Regionally, the market can be segmented into North America, Europe, Asia-Pacific, Latin America and the Middle East and Africa. North America accounts for a larger share of the global humanized mouse model market. This large share is attributed due to increased R&D spending by pharmaceutical companies and increasing biomedical research. Followed by which is Europe and Asia Pacific. The humanized mouse model market is expected to witness a high growth rate in the Asia-Pacific and Latin America reasons being increasing investments from private sector and government in life sciences sector, research in regenerative medicines, increase in animal research, rising focus on personalized medicines, growth in translational and biomedical research, growth in the pharmaceutical industries, and rising pharmaceutical and biotechnology R&D activities in these regions.
Humanized Mouse Model Market: Key Players
Some of the major market players of humanized mouse model market include Ingenious Targeting Laboratory, Axenis S.A.S, Trans Genic Inc., Horizon Discovery Group PLC, HuMurine Technologies, Champions Oncology Inc., Genoway S.A., Crown Bioscience Inc., Taconic Biosciences Inc., The Jackson Laboratory, and Vitalstar Biotechnology Co. Ltd.
MRR.BIZ has been compiled in-depth market research data in the report after exhaustive primary and secondary research. Our team of able, experienced in-house analysts has collated the information through personal interviews and study of industry databases, journals, and reputable paid sources.
The report provides the following information:
The main aim of the report is to:
MRR.BIZ is a leading provider of strategic market research. Our vast repository consists research reports, data books, company profiles, and regional market data sheets. We regularly update the data and analysis of a wide-ranging products and services around the world. As readers, you will have access to the latest information on almost 300 industries and their sub-segments. Both large Fortune 500 companies and SMEs have found those useful. This is because we customize our offerings keeping in mind the specific requirements of our clients.